英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

mutable    
a. 易变的,性情不定的

易变的,性情不定的

mutable
adj 1: capable of or tending to change in form or quality or
nature; "a mutable substance"; "the mutable ways of
fortune"; "mutable weather patterns"; "a mutable foreign
policy" [synonym: {mutable}, {changeable}] [ant:
{changeless}, {immutable}]

Mutable \Mu"ta*ble\, a. [L. mutabilis, fr. mutare to change. See
{Move}.]
1. Capable of alteration; subject to change; changeable in
form, qualities, or nature.
[1913 Webster]

Things of the most accidental and mutable nature.
--South.
[1913 Webster]

2. Changeable; inconstant; unsettled; unstable; fickle. "Most
mutable wishes." --Byron.
[1913 Webster]

Syn: Changeable; alterable; unstable; unsteady; unsettled;
wavering; inconstant; variable; fickle.
[1913 Webster]

133 Moby Thesaurus words for "mutable":
able to adapt, adaptable, adjustable, alterable, alterative,
ambitendent, ambivalent, at loose ends, brittle, capricious,
changeable, changeful, changing, checkered, choppy, corruptible,
deciduous, deviating, deviative, deviatory, different, disorderly,
divaricate, divergent, diversified, diversiform, double-minded,
dubious, dying, ephemeral, erose, erratic, evanescent,
ever-changing, fading, fence-sitting, fence-straddling, fickle,
fleeting, flexible, flitting, fluctuating, fluid, fly-by-night,
flying, fragile, frail, fugacious, fugitive, impermanent,
impetuous, impulsive, inconsistent, inconstant, indecisive,
infirm of purpose, insubstantial, irregular, irresolute,
irresolved, jagged, jerky, kaleidoscopic, lubricious, malleable,
many-sided, mercurial, metamorphic, mobile, modifiable, momentary,
mortal, motley, movable, mugwumpian, mugwumpish, nonconformist,
nondurable, nonpermanent, nonstandard, nonuniform, of two minds,
passing, perishable, permutable, plastic, pluralistic, protean,
proteiform, ragged, resilient, rough, rubbery, shifty,
shilly-shally, short-lived, slippery, spasmodic, sporadic,
subject to death, supple, swaying, swinging, temperamental,
temporal, temporary, ticklish, transient, transitive, transitory,
uncertain, undecided, undetermined, undurable, unenduring,
unequable, unequal, uneven, unorthodox, unresolved, unsettled,
unstable, unsteady, unsystematic, ununiform, vacillating, variable,
variegated, variform, various, varying, volatile, wavering


请选择你想看的字典辞典：
单词字典翻译
mutable查看　mutable　在百度字典中的解释百度英翻中〔查看〕
mutable查看　mutable　在Google字典中的解释Google英翻中〔查看〕
mutable查看　mutable　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Biogen Receives U. S. FDA Breakthrough Therapy Designation for . . .
    Felzartamab, an investigational anti-CD38 monoclonal antibody, is a potential first-in-class therapeutic candidate for a range of rare immune-mediated indications with planning underway for Phase 3 development
  • Biogen shows its IgAN hand with felzartamab data
    Biogen has revealed encouraging phase 2 results with its anti-CD38 antibody felzartamab in rare kidney disease IgA nephropathy (IgAN), which it hopes could join a series of first-in-class
  • Biogen inks $1. 15B HI-Bio buyout to expand in immunology - Fierce Biotech
    Biogen is placing a $1 15 billion bet on Chris Viehbacher’s diversification vision The upfront payment has secured Biogen a deal to buy Human Immunology Biosciences (HI-Bio), a biotech that is
  • 18亿美元！渤健收购HI-Bio获得CD38单抗，天境生物拥有中国权益 5月22日，Biogen宣布收购Human Immunology . . .
    HI-Bio专注于 精准医疗 方法，为免疫介导性疾病（IMD）领域开发免疫疗法，其线中主要资产felzartamab是一种全人源抗CD38单克隆抗体，正在开发用于 多发性骨髓瘤（MM）、原发性膜性肾病（PMN）、抗体介导的排斥反应（AMR）、IgA肾病（IgAN） 等多个适应症的临床研究。 Felzartamab已获得FDA的突破性疗法认定（BTD）用于治疗PMN，并已获得孤儿药认定（ODD）治疗AMR。 目前，Felzartamab用于治疗 PMN 和治疗 AMR 的 2 期研究已经完成，IgA 肾病（IgAN）的 2 期研究仍在进行中，HI-Bio 计划将每个适应症推进到 3 期。
  • CD38 — a new target in renal immune disease - Nature
    Targeting of CD38 has been posited as a potential therapeutic avenue for the treatment of immune-mediated conditions A phase 2 study now reports promising safety, tolerability and intermediate
  • Biogen gets FDA Breakthrough status for felzartamab
    US biotech major Biogen revealed that felzartamab, an investigational anti-CD38 monoclonal antibody, has received Breakthrough Therapy designation (BTD) from the US Food and Drug Administration (FDA) for the treatment of late antibody-mediated rejection (AMR) without T-cell mediated rejection in kidney transplant patients
  • Biogen Highlights the Potential of Felzartamab for a Range of Immune . . .
    Biogen is evaluating additional expansion indications for felzartamab Biogen believes the selective targeting of CD38 positive immune cells may provide felzartamab with a potentially differentiated profile across other indications One example is lupus nephritis (LN), where the company has an ongoing Phase 1 trial
  • Anti-CD38 - BioGenex
    CD38 is a highly expressed transmembrane protein on thymocytes, activated T-cells and terminally differentiated B-cells (plasma cells) It is expressed at high levels in the plasma cell tumor, prostate cancer, stomach cancer, and neuroblastoma CD38 participates in cell adhesion, signal transduction and calcium signaling
  • 18亿美元！Biogen收购免疫疗法公司HI-Bio，核心管线CD38抗体
    HI Bio的主要资产felzartamab（菲泽妥单抗）是一种全人源CD38单克隆抗体，临床研究表明，该抗体可以选择性地消耗CD38+细胞，包括浆细胞和自然杀伤细胞（NK），这可能允许在广泛的免疫介导疾病中提高临床结果的额外应用。 Felzartamab已获得美国FDA颁发的突破性治疗资格（BTD）和孤儿药资格（ODD），用于开发治疗原发性膜性肾病（PMN）的药物，并已获得ODD用于治疗肾移植受者的抗体介导的排斥反应（AMR）。 PMN和AMR的2期研究已经完成，IgA肾病（IgAN）的研究仍在进行中，HI Bio计划将每个适应症推进到3期。
  • Biogen bets $1. 15bn on immunology drug developer HI-Bio
    Biogen has expanded its specialty immunology pipeline with an agreement to buy Human Immunology Biosciences (HI-Bio) and its lead drug felzartamab, in trials for a range of diseases, including





中文字典-英文字典  2005-2009